NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Intel also Approaches TSMC over Potential Investment and Partnership

Intel CEO Lip-Bu Tan is seeking partnerships with Apple and TSMC for investments or manufacturing, meeting with Tim Cook and C. C. Wei.

Intel also Approaches TSMC over Potential Investment and Partnership
“San Jose / CA / USA - Taiwan Semiconductor Manufacturing Company (TSMC) headquarters in Silicon Valley” by 李 季霖, CC BY-SA 2.0
Already have an account? Sign in.
Featured/ 09/25/2025 · 3:35 PM
INTC
/ Don’t stop at just one post.

Related↓

Wall Street Upgrades Intel & AMD: CPU Renaissance Sparks Massive Rally
Featured/ 04/24/2026 · 8:58 AM

Wall Street Upgrades Intel & AMD: CPU Renaissance Sparks Massive Rally

Analysts upgraded Intel and AMD on strong AI-driven CPU demand, raising targets and boosting shares in premarket trading.

/ Subscriber only
Intel Crushes Q1 2026 Earnings — AI CPU Demand Fuels Massive Q2 Beat
Featured/ 04/23/2026 · 4:25 PM

Intel Crushes Q1 2026 Earnings — AI CPU Demand Fuels Massive Q2 Beat

Intel beat Q1 2026 forecasts with strong AI chip demand, higher sales, and upbeat outlook as it works to catch up in AI race.

/ Subscriber only
Tesla to Use Intel Chips in Terafab Project as Capex Jumps to $25 Billion
Featured/ 04/23/2026 · 4:55 AM

Tesla to Use Intel Chips in Terafab Project as Capex Jumps to $25 Billion

Tesla plans to use Intel’s next-gen 14A technology for its Terafab AI chip factory while increasing capital expenditure to $25 billion in 2026.

/ Subscriber only
/ Read more

Feed↓

Teradyne Stock Drops After Record AI-Powered Q1 — But Q2 Guidance Disappoints
04/29/2026 · 1:18 PM

Teradyne Stock Drops After Record AI-Powered Q1 — But Q2 Guidance Disappoints

Teradyne had record sales from AI chip demand, but cautious outlook for next quarter sent shares down despite strong results.

/ Subscriber only
Teva Beats Q1 2026 Forecasts as AUSTEDO & UZEDY Surge — Acquires Emalex for $700M Tourette Drug
Featured/ 04/29/2026 · 11:49 AM

Teva Beats Q1 2026 Forecasts as AUSTEDO & UZEDY Surge — Acquires Emalex for $700M Tourette Drug

Teva buys Emalex for $700M to add a new Tourette drug. Strong sales growth led by key medicines; generics weaker but outlook solid.

/ Subscriber only
Chiesi Buys KalVista for $1.9 Billion in Biggest Deal Yet to Strengthen Rare Disease Portfolio
Featured/ 04/29/2026 · 8:41 AM

Chiesi Buys KalVista for $1.9 Billion in Biggest Deal Yet to Strengthen Rare Disease Portfolio

Chiesi will buy KalVista for $1.9B to get EKTERLY, a new oral rare disease drug, and grow its global rare disease business.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe